Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Fate Therapeutics (FATE)

Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down Zacks Investment Research - Fri Oct 25, 10:18AM CDT

Alkermes plc ALKS reported adjusted earnings from continuing operations of 73 cents per share for third-quarter 2024, which missed the Zacks Consensus Estimate of 78 cents. The company had reported adjusted...

CSTL : 33.15 (-4.38%)
ELEV : 0.5360 (-6.67%)
FATE : 2.43 (+2.53%)
ALKS : 26.47 (+3.00%)
VKTX Beats on Q3 Earnings, Stock Up on Obesity Pipeline Advancements
VKTX Beats on Q3 Earnings, Stock Up on Obesity Pipeline Advancements Zacks Investment Research - Thu Oct 24, 9:28AM CDT

Viking Therapeutics VKTX reported third-quarter 2024 loss per share of 22 cents, narrower than the Zacks Consensus Estimate of a loss of 24 cents. The company had incurred a loss of 23 cents per share...

FOLD : 11.47 (+0.44%)
VKTX : 72.88 (+0.47%)
CSTL : 33.15 (-4.38%)
FATE : 2.43 (+2.53%)
Fate Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 13, 3:25PM CDT

Fate Therapeutics: Q2 Earnings Snapshot

FATE : 2.43 (+2.53%)
Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? Motley Fool - Sun Jul 21, 4:37AM CDT

The Baker brothers are billionaires with a successful track record in the biopharmaceutical industry.

MRK : 101.88 (-0.43%)
LLY : 818.93 (-1.30%)
PFE : 28.09 (-0.74%)
OPHLY : 4.2300 (+2.42%)
ABCL : 2.73 (unch)
FATE : 2.43 (+2.53%)
Fate Therapeutics: Q1 Earnings Snapshot AP - Thu May 9, 3:21PM CDT

Fate Therapeutics: Q1 Earnings Snapshot

FATE : 2.43 (+2.53%)
Wall Street - Fearless girl standing tall -xHUZuSwVJg4-unsplash
5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024 Barchart - Wed Mar 13, 12:24PM CDT

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap...

GOOGL : 171.29 (+0.11%)
AMZN : 197.93 (+6.19%)
AAPL : 222.91 (-1.33%)
META : 567.16 (-0.07%)
MSFT : 410.37 (+0.99%)
NVDA : 135.40 (+1.99%)
TSLA : 248.98 (-0.35%)
MAGS : 48.02 (+1.18%)
$IUXX : 20,033.14 (+0.72%)
VKTX : 72.88 (+0.47%)
SOUN : 5.14 (+2.19%)
APGE : 54.49 (+4.71%)
Fate Therapeutics: Q4 Earnings Snapshot AP - Mon Feb 26, 3:08PM CST

Fate Therapeutics: Q4 Earnings Snapshot

FATE : 2.43 (+2.53%)
Fate Therapeutics: Q3 Earnings Snapshot AP - Wed Nov 8, 2023

Fate Therapeutics: Q3 Earnings Snapshot

FATE : 2.43 (+2.53%)
Fate Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Fate Therapeutics: Q2 Earnings Snapshot

FATE : 2.43 (+2.53%)
Why Shares of Fate Therapeutics Soared This Week Motley Fool - Fri Jun 16, 2023

The company's shares bounced back after a stock sale last week.

JNJ : 160.13 (+0.17%)
OPHLY : 4.2300 (+2.42%)
FATE : 2.43 (+2.53%)
MFG : 4.31 (+1.89%)

Barchart Exclusives

3 ETFs to Ride the Tesla Wave and the EV Revolution Barchart - 20 minutes ago
The electric vehicle (EV) sector is gaining momentum, with Tesla's recent performance sparking renewed interest in the space. Three ETFs - KARS, DRIV, and TSLL - offer investors different ways to tap into the EV trend, with each fund providing a unique blend of exposure to traditional automakers, tech innovators, and other players in the EV ecosystem. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot